ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China flag China · Delayed Price · Currency is CNY
26.60
-0.30 (-1.12%)
Aug 20, 2026, 3:00 PM CST

ChengDu ShengNuo Biotec Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
905.06735.37451.08431.32386.88369.3
Other Revenue
6.096.094.993.78.8417.23
911.15741.46456.07435.02395.72386.53
Revenue Growth
53.21%62.58%4.84%9.93%2.38%2.05%
Cost of Revenue
392.66328.87202.84163.38142.39110.67
Gross Profit
518.49412.59253.23271.64253.33275.86
Selling, General & Admin
171.35137.66126.53161.01157.82190.73
Research & Development
6154.9149.1729.0523.2913.75
Other Operating Expenses
7.084.293.111.244.724.8
Operating Expenses
244.53201.96187.17194.37188.29210.14
Operating Income
273.97210.6366.0677.2765.0465.71
Interest Expense
-15.14-15.14-11.8-9.08-3.24-0.17
Interest & Investment Income
2.043.463.753.924.574.2
Currency Exchange Gain (Loss)
-0.76-0.760.780.53-0.67
Other Non Operating Income (Expenses)
-12.22-2.56-0.21-0.29-1.55-0.5
EBT Excluding Unusual Items
247.88195.6258.5772.3367.8268.58
Gain (Loss) on Sale of Investments
0.410.250.16-1.42--
Gain (Loss) on Sale of Assets
-0.060.01--0.91-0.39-4.89
Asset Writedown
0.78-1.54-0.59---
Other Unusual Items
-5.21-5.213.3710.124.936.8
Pretax Income
243.79189.1361.5180.1272.3670.49
Income Tax Expense
39.6231.2411.679.87.889.24
Earnings From Continuing Operations
204.17157.8949.8470.3264.4861.25
Minority Interest in Earnings
-00.030.190.01--
Net Income
204.16157.9250.0270.3464.4861.25
Net Income to Common
204.16157.9250.0270.3464.4861.25
Net Income Growth
74.21%215.70%-28.88%9.08%5.28%2.09%
Shares Outstanding (Basic)
221221219219218198
Shares Outstanding (Diluted)
221221219222218198
Shares Change
1.43%1.03%-1.60%2.04%10.22%20.09%
EPS (Basic)
0.930.710.230.320.300.31
EPS (Diluted)
0.930.710.230.320.300.31
EPS Growth
71.76%212.47%-27.73%6.89%-4.49%-14.98%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
46.1632.68-222.2-193.2-40.23-11.81
Free Cash Flow Per Share
0.210.15-1.01-0.87-0.18-0.06
Dividend Per Share
0.2510.2510.0710.1020.0910.109
Dividend Growth
251.96%251.96%-30.00%11.96%-16.65%-
Gross Margin
56.90%55.65%55.52%62.44%64.02%71.37%
Operating Margin
30.07%28.41%14.49%17.76%16.44%17.00%
Profit Margin
22.41%21.30%10.97%16.17%16.30%15.85%
Free Cash Flow Margin
5.07%4.41%-48.72%-44.41%-10.17%-3.06%
EBITDA
346.35266.53100.62104.9288.7783.65
EBITDA Margin
38.01%35.95%22.06%24.12%22.43%21.64%
D&A For EBITDA
72.3855.934.5627.6523.7217.94
EBIT
273.97210.6366.0677.2765.0465.71
EBIT Margin
30.07%28.41%14.49%17.76%16.44%17.00%
Effective Tax Rate
16.25%16.52%18.98%12.23%10.89%13.10%
Revenue as Reported
741.46741.46456.07435.02395.72386.53
Advertising Expenses
-2.691.920.50.090.18